U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MAP3K12 mitogen-activated protein kinase kinase kinase 12 [ Homo sapiens (human) ]

    Gene ID: 7786, updated on 12-Sep-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress cell proliferation and invasion in prostate cancer by regulating MAP3K12

    Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12.
    Yu J, Feng Y, Wang Y, An R.

    07/6/2019
    LZK cooperates with DLK to promote retinal ganglion cell death in response to axon injury.

    Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons.
    Welsbie DS, Mitchell KL, Jaskula-Ranga V, Sluch VM, Yang Z, Kim J, Buehler E, Patel A, Martin SE, Zhang PW, Ge Y, Duan Y, Fuller J, Kim BJ, Hamed E, Chamling X, Lei L, Fraser IDC, Ronai ZA, Berlinicke CA, Zack DJ., Free PMC Article

    08/5/2017
    REVIEW: Regulation of Beta-Cell Function and Mass by the Dual Leucine Zipper Kinase

    Regulation of Beta-Cell Function and Mass by the Dual Leucine Zipper Kinase.
    Oetjen E.

    03/25/2017
    miR-130a inhibited the JNK pathway by targeting MAP3K12, contributing to its anti-apoptotic effect and the maintenance of diabetic endothelial progenitor cell function.

    MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function.
    Ye M, Li D, Yang J, Xie J, Yu F, Ma Y, Zhu X, Zhao J, Lv Z.

    02/27/2016
    Data suggest that specific pharmacological inhibition of dual leucine zipper kinase (DLK, MAP3K12) may have therapeutic potential in multiple indications of neuronal degeneration.

    Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models.
    Patel S, Cohen F, Dean BJ, De La Torre K, Deshmukh G, Estrada AA, Ghosh AS, Gibbons P, Gustafson A, Huestis MP, Le Pichon CE, Lin H, Liu W, Liu X, Liu Y, Ly CQ, Lyssikatos JP, Ma C, Scearce-Levie K, Shin YG, Solanoy H, Stark KL, Wang J, Wang B, Zhao X, Lewcock JW, Siu M.

    05/2/2015
    these findings indicate that DLK participates in cell proliferation and/or survival, at least in part, by modulating the expression of cell cycle regulatory proteins.

    Loss of DLK expression in WI-38 human diploid fibroblasts induces a senescent-like proliferation arrest.
    Daviau A, Couture JP, Blouin R.

    12/10/2011
    The results confirm the significance of apoptosis deregulation in CLL, and suggest a possible relationship between ZIPK expression and the clinical course of the disease.

    Assessment of the pathway of apoptosis involving PAR-4, DAXX and ZIPK proteins in CLL patients and its relationship with the principal prognostic factors.
    Bojarska-Junak A, Sieklucka M, Hus I, Wąsik-Szczepanek E, Kusz ML, Surdacka A, Chocholska S, Dmoszyńska A, Roliński J.

    10/29/2011
    the DLK-ERK signaling pathway may act as a regulator of the interaction that occurs between Hsp27 and the cytoskeleton during the formation of the cornified cell envelope, a process conferring to the skin its crucial barrier function

    The small heat-shock protein Hsp27 undergoes ERK-dependent phosphorylation and redistribution to the cytoskeleton in response to dual leucine zipper-bearing kinase expression.
    Robitaille H, Simard-Bisson C, Larouche D, Tanguay RM, Blouin R, Germain L.

    02/1/2010
    Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)

    Genetic variation in MicroRNA genes and risk of oral premalignant lesions.
    Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X., Free PMC Article

    12/2/2009
    Observational study of gene-disease association. (HuGE Navigator)

    The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
    Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Pérez L, Schiavi F, Leskelä S, Pita G, Milne R, Maravall J, Ramos I, Andía V, Rodríguez-Poyo P, Jara-Albarrán A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Picó A, Pomares F, Giménez G, López-Mondéjar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodríguez-Antona C, González-Neira A, Matías-Guiu X, Santisteban P, Robledo M., Free PMC Article

    12/2/2009
    Src-dependent tyrosine phosphorylation recombinant human DLK was important for regulation of its activity. DLK may have a role in PDGF signaling.

    The mixed-lineage kinase DLK undergoes Src-dependent tyrosine phosphorylation and activation in cells exposed to vanadate or platelet-derived growth factor (PDGF).
    Daviau A, Di Fruscio M, Blouin R.

    01/21/2010
    DAPK-ZIPK-L13a axis forms a unique regulatory module that first represses, then repermits inflammatory gene expression.

    DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression.
    Mukhopadhyay R, Ray PS, Arif A, Brady AK, Kinter M, Fox PL., Free PMC Article

    01/21/2010
    for the selective expression of ZPK gene, cell-specific negative regulatory element(s) which locate outside of the core promoter region repress the potent basic promoter activity

    SP3 acts as a positive regulator on the core promoter of human ZPK gene.
    Itoh A, Wang Z, Ito Y, Reddy UR, Itoh T.

    01/21/2010
    DLK is a signaling molecule implicated in the regulation of keratinocyte terminal differentiation and cornification

    The mitogen-activated protein kinase kinase kinase dual leucine zipper-bearing kinase (DLK) acts as a key regulator of keratinocyte terminal differentiation.
    Robitaille H, Proulx R, Robitaille K, Blouin R, Germain L.

    01/21/2010
    ZIPK is positively regulated by phosphorylation within its kinase domain and contains an inhibitory C-terminal domain that controls enzyme activity.

    Regulation of zipper-interacting protein kinase activity in vitro and in vivo by multisite phosphorylation.
    Graves PR, Winkfield KM, Haystead TA.

    01/21/2010
    firstprevious page of 1 nextlast